
Home
Chapter Home
Jobs
Conferences
Fellowships
Books
Advertisement
Kidney tumor - cysts, children, adult benign
Childhood neoplasms
Translocation carcinoma
Reviewers: Mandolin Ziadie, M.D. (see Reviewers page)
Revised: 13 January 2012, last major update January 2012
Copyright: (c) 2003-2012, PathologyOutlines.com, Inc.
General
=========================================================================
● Pediatric renal cell carcinoma with translocations involving TFE3 transcription factor gene (Xp11.2) or TFEB protein (11q12)
● Also called MiT translocation subgroup carcinomas
Epidemiology
=========================================================================
● Represents 33-73% of pediatric renal cell carcinomas (Cancer 2008;112:1607)
Clinical features
=========================================================================
● Associated with prior chemotherapy (J Clin Oncol 2006;24:1529)
● Presents at high stage with poor prognosis (Histopathology 2008;53:533)
Gross description
=========================================================================
● Tan-yellow, frequent hemorrhage and necrosis
Gross images
=========================================================================
Multiple partially cystic and hemorrhagic tumor nodules with fibrous septa
Micro description
=========================================================================
● Cells with abundant clear or granular, eosinophilic cytoplasm with sharp borders and irregular nuclei with vesicular chromatin and small nucleoli
● Cells are arranged in septa separated by thin-walled vessels in papilla or nests
● Calcifications are frequent
● A tubular / nested architecture is more common in t(6;11) tumors
● Some may show solid / acinar / alveolar / tubular patterns
● Mitoses are rare / absent
● Cases with TFE translocations rarely have melanin pigment and morphologically resemble PEComas (Am J Surg Pathol 2009;33:609)
Micro images
=========================================================================
Virtual slides
=========================================================================
Xp11.2 translocation-associated carcinoma
Positive stains
=========================================================================
● RCC, TFE3 (nuclear staining) or TFEB (nuclear staining), CD10, AMACR and vimentin
● Also E-cadherin (2/3), cytokeratin (30-50%, focal) and EMA (50%, frequently only focal)
● Weak expression of melanocytic markers (Am J Surg Pathol 2002;26:1553, Am J Surg Pathol 2008;32:656)
● Also p21, cyclin D1 (Pathol Res Pract 2009;205:466)
Negative stains
=========================================================================
● CD45, HMB45 (some t(6;11) tumors show focal positivity), calretinin, smooth muscle actin and p53
Molecular description
=========================================================================
● t(X;17)(p11.2;q25) - balanced translocation of TFE3 gene at Xp11.2 and ASPL gene at 17q25; also found in alveolar soft part sarcoma, but unbalanced
● t(X;1)(p11.2;q21) - TFE3 and PRCC genes
● t(6;11)(p21;q12) - TFEB and alpha genes; appear to have low malignant potential in contrast to other translocation carcinomas (Am J Surg Pathol 2005;29:230)
● Hereditary papillary carcinoma has t(X;1)(p11.2; p34) - fusion of TFE3 and PSF
Electron microscopy
=========================================================================
● Features of clear cell carcinoma, including cell junctions, numerous mitochondria, microvilli, basement membrane and abundant glycogen
Differential diagnosis
=========================================================================
● Clear cell renal cell carcinoma: usually older patients, no papillary pattern, vimentin+, keratin+, TFE3-, 3p- and no intracisternal microtubules on EM
● Papillary renal cell carcinoma: predominantly papillary, no nested alveolar patterns, no extensive areas of clear cells, keratin+, TFE3-, trisomy 7 and 17
● Clear cell sarcoma of kidney: TFE3-
End of Kidney tumor - cysts, children, adult benign > Childhood neoplasms > Translocation carcinoma
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com
with any questions (click here for other
contact information).